Ligand Pharmaceuticals (LGND) Receivables - Other (2010 - 2015)
Ligand Pharmaceuticals (LGND) posted Receivables - Other of $88000.0 for Q1 2015, down 72.67% sequentially from $322000.0 in Q4 2014, and down 87.21% YoY from $688000.0 in Q1 2014.
Ligand Pharmaceuticals (LGND) Receivables - Other (2010 - 2015) Analysis & Trends
Ligand Pharmaceuticals has reported Receivables - Other for 6 years, with the latest figure at $88000.0 in Q1 2015.
- Quarterly Receivables - Other fell 87.21% year-over-year to $88000.0 in Q1 2015, while the trailing twelve-month figure through Mar 2015 was $88000.0 (down 87.21% YoY) and the FY2014 annual result came in at $4.3 million, changed 0.0% from the prior year.
- Receivables - Other retreated to $88000.0 in Q1 2015 per LGND's latest filing, from $322000.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $8.0 million in Q3 2011 and troughed at $88000.0 in Q1 2015.
- A 5-year average of $3.8 million and a median of $4.4 million in 2012 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2013 and 2014: Receivables - Other rose 1.72% in 2013, then tumbled 92.56% in 2014.
- Over 5 years, Receivables - Other stood at $6.2 million in 2011, then plunged by 30.18% to $4.3 million in 2012, then rose by 0.05% to $4.3 million in 2013, then sank by 92.56% to $322000.0 in 2014, then tumbled by 72.67% to $88000.0 in 2015.
- According to Business Quant data, Receivables - Other over the past three periods registered $88000.0, $322000.0, and $523000.0 for Q1 2015, Q4 2014, and Q3 2014 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ligand Pharmaceuticals | 5.87 Bn | 4.51 Bn | 60.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 88,000.00 |
| Mar 31, 2015 | 88,000.00 |
| Dec 31, 2014 | 322,000.00 |
| Dec 31, 2014 | 322,000.00 |
| Sep 30, 2014 | 523,000.00 |
| Sep 30, 2014 | 523,000.00 |
| Jun 30, 2014 | 391,000.00 |
| Jun 30, 2014 | 391,000.00 |
| Mar 31, 2014 | 688,000.00 |
| Mar 31, 2014 | 688,000.00 |
| Dec 31, 2013 | 4.33 Mn |
| Dec 31, 2013 | 4.33 Mn |
| Sep 30, 2013 | 4.51 Mn |
| Sep 30, 2013 | 4.51 Mn |
| Jun 30, 2013 | 4.47 Mn |
| Jun 30, 2013 | 4.47 Mn |
| Mar 31, 2013 | 4.26 Mn |
| Mar 31, 2013 | 4.26 Mn |
| Dec 31, 2012 | 4.33 Mn |
| Dec 31, 2012 | 4.33 Mn |